Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Turley

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Medicine|March 4, 2016
Biological and Prognostic Significance of the Morphological Types and Vascular Patterns in Colorectal Liver Metastases (CRLM): Looking Beyond the Tumor MarginPulathis N Siriwardana, Tu Vinh Luong, Jennifer Watkins, et al.
Translational Oncology|August 25, 2024
Low cytoplasmic NUB1 protein exerts hypoxic cell death with poorer prognosis in oestrogen receptor negative breast cancer patientsKa-Liong Tan, Syed Haider, Christos E Zois, et al.
The Journal of Pathology|September 5, 2002
Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's diseaseIpatia A Doussis-Anagnostopoulou, Kate L Talks, Helen Turley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2003
Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancerDaniel E B Swinson, J Louise Jones, Donna Richardson, et al.
Cancer|July 11, 2006
The relation between hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression with anemia and outcome in surgically treated head and neck cancerStuart C Winter, Ketan A Shah, Cheng Han, et al.
The Journal of Biological Chemistry|July 13, 2004
Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factorRebecca J Appelhoff, Ya-Min Tian, Raju R Raval, et al.
Translational Oncology|April 12, 2025
Corrigendum to "Low cytoplasmic NUB1 protein exerts hypoxic cell death with poorer prognosis in oestrogen receptor negative breast cancer patients" [Translational Oncology, volume 49 (2024), 102106]Ka-Liong Tan, Syed Haider, Christos E Zois, et al.
The Journal of Urology|February 22, 2011
Nuclear localization of factor inhibitor hypoxia-inducible factor in prostate cancer is associated with poor prognosisNadeem Shaida, Peter Chan, Helen Turley, et al.
Cancer Research|August 5, 2010
The histone demethylase JMJD2B is regulated by estrogen receptor alpha and hypoxia, and is a key mediator of estrogen induced growthJun Yang, Adrian M Jubb, Luke Pike, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2009
Gastrointestinal differentiation marker Cytokeratin 20 is regulated by homeobox gene CDX1Carol W M Chan, Newton A Wong, Ying Liu, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Medicine|March 4, 2016
Biological and Prognostic Significance of the Morphological Types and Vascular Patterns in Colorectal Liver Metastases (CRLM): Looking Beyond the Tumor MarginPulathis N Siriwardana, Tu Vinh Luong, Jennifer Watkins, et al.
Translational Oncology|August 25, 2024
Low cytoplasmic NUB1 protein exerts hypoxic cell death with poorer prognosis in oestrogen receptor negative breast cancer patientsKa-Liong Tan, Syed Haider, Christos E Zois, et al.
The Journal of Pathology|September 5, 2002
Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's diseaseIpatia A Doussis-Anagnostopoulou, Kate L Talks, Helen Turley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2003
Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancerDaniel E B Swinson, J Louise Jones, Donna Richardson, et al.
Cancer|July 11, 2006
The relation between hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression with anemia and outcome in surgically treated head and neck cancerStuart C Winter, Ketan A Shah, Cheng Han, et al.
The Journal of Biological Chemistry|July 13, 2004
Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factorRebecca J Appelhoff, Ya-Min Tian, Raju R Raval, et al.
Translational Oncology|April 12, 2025
Corrigendum to "Low cytoplasmic NUB1 protein exerts hypoxic cell death with poorer prognosis in oestrogen receptor negative breast cancer patients" [Translational Oncology, volume 49 (2024), 102106]Ka-Liong Tan, Syed Haider, Christos E Zois, et al.
The Journal of Urology|February 22, 2011
Nuclear localization of factor inhibitor hypoxia-inducible factor in prostate cancer is associated with poor prognosisNadeem Shaida, Peter Chan, Helen Turley, et al.
Cancer Research|August 5, 2010
The histone demethylase JMJD2B is regulated by estrogen receptor alpha and hypoxia, and is a key mediator of estrogen induced growthJun Yang, Adrian M Jubb, Luke Pike, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2009
Gastrointestinal differentiation marker Cytokeratin 20 is regulated by homeobox gene CDX1Carol W M Chan, Newton A Wong, Ying Liu, et al.
Pageof 7